Clinical Trial Update: Modulation of Stem Cell Differentiation in Individuals With High Risk Clonal Haematopoiesis [Phase 2]

View source ↗

Summary

This clinical trial update notes a Phase 2 study evaluating methods to modulate stem cell differentiation in individuals at high risk of clonal hematopoiesis. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clonal Cytopenia of Uncertain Significance
• Clonal Hematopoiesis

Drugs mentioned

• Not disclosed

Snippet

Sponsor: Clinical Hub for Interventional Research (CHOIR) | Conditions: Clonal Cytopenia of Uncertain Significance, CCUS Clonal Cytopenia of Undetermined Significance | Phase 2 | Status: NOT_YET_RECRUITING